CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 102 entries

View as:

Study Evaluating the Treatment of Occipital Neuralgia

Phase: N/A Priority: Normal

NCT ID: NCT01753765 Org: User:

Start: 10/31/12 End: 07/31/14 Due: 07/31/15

Innovations in Genicular Outcomes Registry

Phase: N/A Priority: Normal

NCT ID: NCT05495334 Org: User:

Start: 09/23/21 End: 06/30/27 Due: 06/30/28

Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty

Phase: N/A Priority: Normal

NCT ID: NCT02713490 Org: User:

Start: 04/18/16 End: 02/08/17 Due: 02/08/18

Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee

Phase: N/A Priority: Normal

NCT ID: NCT02637323 Org: User:

Start: 11/30/15 End: 09/30/16 Due: 09/30/17

Adult Patients Undergoing Open Colectomy MA402S23B303

Phase: N/A Priority: Normal

NCT ID: NCT01507246 Org: User:

Start: 12/31/11 End: 08/31/12 Due: 08/31/13

Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00806806 Org: User:

Start: 10/31/08 End: 02/28/09 Due: 02/28/10

Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

Phase: N/A Priority: Normal

NCT ID: NCT04826328 Org: User:

Start: 03/15/21 End: 03/30/22 Due: 03/30/23

Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

Phase: N/A Priority: Normal

NCT ID: NCT03485014 Org: User:

Start: 04/10/18 End: 02/12/19 Due: 02/12/20

A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501

Phase: N/A Priority: Normal

NCT ID: NCT01509638 Org: User:

Start: 03/31/12 End: 10/31/12 Due: 10/31/13

Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty

Phase: N/A Priority: Normal

NCT ID: NCT02713178 Org: User:

Start: 06/03/16 End: 06/30/17 Due: 06/30/18

A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302

Phase: N/A Priority: Normal

NCT ID: NCT01507233 Org: User:

Start: 05/31/12 End: 07/31/12 Due: 07/31/13

Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty

Phase: N/A Priority: Normal

NCT ID: NCT02284386 Org: User:

Start: 12/31/14 End: 03/31/15 Due: 03/31/16

Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA

Phase: N/A Priority: Normal

NCT ID: NCT02922582 Org: User:

Start: 10/28/16 End: 11/27/17 Due: 11/27/18

Dose Finding Posterolateral Thoracotomy Study

Phase: N/A Priority: Normal

NCT ID: NCT00807209 Org: User:

Start: 12/31/08 End: 02/28/09 Due: 02/28/10

Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT02762370 Org: User:

Start: 04/30/16 End: 11/30/16 Due: 11/30/17

Study in Adult Subjects Undergoing Posterolateral Thoracotomy

Phase: N/A Priority: Normal

NCT ID: NCT03428984 Org: User:

Start: 05/03/18 End: 09/28/18 Due: 09/28/19

TAP-patients With Robotic Assisted Lap Prostatectomy

Phase: N/A Priority: Normal

NCT ID: NCT01582477 Org: User:

Start: 03/31/12 End: 07/31/12 Due: 07/31/13

Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy

Phase: N/A Priority: Normal

NCT ID: NCT04002089 Org: User:

Start: 07/26/19 End: 12/02/19 Due: 12/02/20

Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation

Phase: N/A Priority: Normal

NCT ID: NCT00813111 Org: User:

Start: 11/30/08 End: 02/28/09 Due: 02/28/10

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation

Phase: N/A Priority: Normal

NCT ID: NCT04293809 Org: User:

Start: 12/19/19 End: 01/29/20 Due: 01/29/21

DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

Phase: N/A Priority: Normal

NCT ID: NCT00029523 Org: User:

Start: 04/30/01 End: 11/30/04 Due: 11/30/05

Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction

Phase: N/A Priority: Normal

NCT ID: NCT03909516 Org: User:

Start: 05/01/19 End: 05/01/19 Due: 05/01/20

EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture

Phase: N/A Priority: Normal

NCT ID: NCT03955458 Org: User:

Start: 08/26/19 End: 05/31/20 Due: 05/31/21

Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair

Phase: N/A Priority: Normal

NCT ID: NCT01203644 Org: User:

Start: 12/31/04 End: 12/31/06 Due: 12/31/07

Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy

Phase: N/A Priority: Normal

NCT ID: NCT02199574 Org: User:

Start: 08/31/14 End: 06/30/15 Due: 06/30/16

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Study Evaluating the Treatment of Occipital Neuralgia	NCT01753765	Pacira Pharmaceuticals, Inc	user2@example.com	None	2012-10-31	2014-07-31	2015-07-31	-	-	2025-07-14
Innovations in Genicular Outcomes Registry	NCT05495334	Pacira Pharmaceuticals, Inc	user2@example.com	None	2021-09-23	2027-06-30	2028-06-30	-	-	2025-07-14
Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty	NCT02713490	Pacira Pharmaceuticals, Inc	user2@example.com	None	2016-04-18	2017-02-08	2018-02-08	-	-	2025-07-14
Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee	NCT02637323	Pacira Pharmaceuticals, Inc	user2@example.com	None	2015-11-30	2016-09-30	2017-09-30	-	-	2025-07-14
Adult Patients Undergoing Open Colectomy MA402S23B303	NCT01507246	Pacira Pharmaceuticals, Inc	user2@example.com	None	2011-12-31	2012-08-31	2013-08-31	-	-	2025-07-14
Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers	NCT00806806	Pacira Pharmaceuticals, Inc	user2@example.com	None	2008-10-31	2009-02-28	2010-02-28	-	-	2025-07-14
Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy	NCT04826328	Pacira Pharmaceuticals, Inc	user2@example.com	None	2021-03-15	2022-03-30	2023-03-30	-	-	2025-07-14
Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL	NCT03485014	Pacira Pharmaceuticals, Inc	user2@example.com	None	2018-04-10	2019-02-12	2020-02-12	-	-	2025-07-14
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501	NCT01509638	Pacira Pharmaceuticals, Inc	user2@example.com	None	2012-03-31	2012-10-31	2013-10-31	-	-	2025-07-14
Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty	NCT02713178	Pacira Pharmaceuticals, Inc	user2@example.com	None	2016-06-03	2017-06-30	2018-06-30	-	-	2025-07-14
A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302	NCT01507233	Pacira Pharmaceuticals, Inc	user2@example.com	None	2012-05-31	2012-07-31	2013-07-31	-	-	2025-07-14
Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty	NCT02284386	Pacira Pharmaceuticals, Inc	user2@example.com	None	2014-12-31	2015-03-31	2016-03-31	-	-	2025-07-14
Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA	NCT02922582	Pacira Pharmaceuticals, Inc	user2@example.com	None	2016-10-28	2017-11-27	2018-11-27	-	-	2025-07-14
Dose Finding Posterolateral Thoracotomy Study	NCT00807209	Pacira Pharmaceuticals, Inc	user2@example.com	None	2008-12-31	2009-02-28	2010-02-28	-	-	2025-07-14
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes	NCT02762370	Pacira Pharmaceuticals, Inc	user2@example.com	None	2016-04-30	2016-11-30	2017-11-30	-	-	2025-07-14
Study in Adult Subjects Undergoing Posterolateral Thoracotomy	NCT03428984	Pacira Pharmaceuticals, Inc	user2@example.com	None	2018-05-03	2018-09-28	2019-09-28	-	-	2025-07-14
TAP-patients With Robotic Assisted Lap Prostatectomy	NCT01582477	Pacira Pharmaceuticals, Inc	user2@example.com	None	2012-03-31	2012-07-31	2013-07-31	-	-	2025-07-14
Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy	NCT04002089	Pacira Pharmaceuticals, Inc	user2@example.com	None	2019-07-26	2019-12-02	2020-12-02	-	-	2025-07-14
Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation	NCT00813111	Pacira Pharmaceuticals, Inc	user2@example.com	None	2008-11-30	2009-02-28	2010-02-28	-	-	2025-07-14
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation	NCT04293809	Pacira Pharmaceuticals, Inc	user2@example.com	None	2019-12-19	2020-01-29	2021-01-29	-	-	2025-07-14
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor	NCT00029523	Pacira Pharmaceuticals, Inc	user2@example.com	None	2001-04-30	2004-11-30	2005-11-30	-	-	2025-07-14
Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction	NCT03909516	Pacira Pharmaceuticals, Inc	user2@example.com	None	2019-05-01	2019-05-01	2020-05-01	-	-	2025-07-14
EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture	NCT03955458	Pacira Pharmaceuticals, Inc	user2@example.com	None	2019-08-26	2020-05-31	2021-05-31	-	-	2025-07-14
Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair	NCT01203644	Pacira Pharmaceuticals, Inc	user2@example.com	None	2004-12-31	2006-12-31	2007-12-31	-	-	2025-07-14
Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy	NCT02199574	Pacira Pharmaceuticals, Inc	user2@example.com	None	2014-08-31	2015-06-30	2016-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance